搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 2 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics Startup
Forbes· 23 小時前The U.S. healthcare system is not set up to take care of a kid with a rash or a fever at 2 a.m. ...
U.S. FDA approves ImmunityBio's bladder cancer therapy
Reuters· 2 日前, opens new tab combination therapy to treat a type of bladder cancer, marking an end to the ...
Clean Away: An Earth Day Essay And Thank You From Artist Sage Bava
Forbes· 3 日前The relationship between music and nature is a long and storied one. From Neil Young’s ...